Online citations, reference lists, and bibliographies.
← Back to Search

Nanoscale Particle Therapies For Wounds And Ulcers.

R. Cortivo, V. Vindigni, L. Iacobellis, G. Abatangelo, P. Pinton, B. Zavan
Published 2010 · Business, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
'Small is beautiful' - this should be the slogan of nanoscientists. Indeed, working with particles less than 100 nm in size, nanotechnology is on the verge of providing a host of new materials and approaches, revolutionizing applied medicine. The obvious potential of nanotechnology has attracted considerable investment from governments and industry hoping to drive its economic development. Several areas of medical care already benefit from the advantages that nanotechnology provides and its application in wound healing will be reviewed in this article.
This paper references
10.1186/1745-6673-2-16
Nanotechnology-based drug delivery systems
S. Suri (2007)
10.1242/jcs.031187
Wound repair at a glance
T. Shaw (2009)
10.1073/pnas.0905432106
Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles
F. Yang (2009)
10.2174/138161209787002870
Targeted drugs and nanomedicine: present and future.
P. Debbage (2009)
10.1080/03639040802026012
Polymers for Mucoadhesive Drug Delivery System: A Current Status
G. S. Asane (2008)
10.1016/j.amjmed.2009.05.031
Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?
Kathleen A Hazlewood (2010)
10.1016/J.NANO.2004.12.001
Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
A. Thote (2005)
10.1016/J.EJPS.2006.05.005
Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs.
F. Ungaro (2006)
10.1016/J.IJPHARM.2005.04.017
Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier.
I. Kim (2005)
10.3233/CBM-2009-0578
Overview of nanoparticle use in cancer imaging.
T. Islam (2009)
10.1111/j.1472-8206.2009.00692.x
Emerging trends of nanomedicine – an overview
S. Sandhiya (2009)
10.1111/j.1523-5378.2009.00704.x
Treatment of Helicobacter pylori Infection
A. O’Connor (2009)
10.1016/J.BIOCEL.2007.10.024
Metalloproteinases and their inhibitors: regulators of wound healing.
S. Gill (2008)
Biology of metalloproteinases.
C. Amălinei (2007)
10.2174/187221109788452258
Nanoparticles for gene delivery: a brief patent review.
G. Xu (2009)
10.1016/J.EURURO.2007.06.036
Investigation of the antifibrotic effect of IFN-gamma on fibroblasts in a cell culture model of Peyronie's disease.
S. M. Haag (2008)
10.1096/fj.05-4802fje
In vivo regeneration of small‐diameter (2 mm) arteries using a polymer scaffold
S. Lepidi (2006)
10.1016/j.biomaterials.2009.07.027
On the nature of biomaterials.
D. F. Williams (2009)
10.1016/j.biomaterials.2009.02.036
Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Y. Lin (2009)
Ag+ alters cell growth, neurite extension, cardiomyocyte beating, and fertilized egg constriction.
A. Conrad (1999)
10.1016/j.molcel.2009.09.021
Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence.
P. Adams (2009)
10.1083/JCB.140.4.947
Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro
S. Esser (1998)
10.1016/S0168-3659(01)00400-X
Preparation and evaluation of poly(L-lactic acid) microspheres containing rhEGF for chronic gastric ulcer healing.
K. Han (2001)
Skin and soft tissue infections due to CA-MRSA.
Dan Scheurich (2009)
10.1016/j.ejps.2009.04.004
Quantifying drug release from PLGA nanoparticulates.
O. Corrigan (2009)
10.1080/10611860701733278
Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori
S. Ramteke (2008)
10.1016/J.BIOMATERIALS.2004.04.006
Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles.
F. Chellat (2005)
10.1016/j.biomaterials.2009.09.093
Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles.
O. Ziv-Polat (2010)
10.1038/ncpgasthep1138
New concepts of resistance in the treatment of Helicobacter pylori infections
D. Graham (2008)
10.1016/j.cps.2009.05.009
Burn reconstruction: the problems, the techniques, and the applications.
D. Wainwright (2009)
10.1016/J.IJPHARM.2006.06.005
Preparation of vancomycin microparticles: importance of preparation parameters.
W. Hachicha (2006)
Clinical experience with wound biofilm and management: a case series.
J. Hurlow (2009)
10.1007/S11883-008-0024-0
Novel markers of inflammation in atherosclerosis
S. Virani (2008)
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
N. Slatkin (2007)
10.1016/j.nano.2009.01.015
Physical properties and biological activity of poly(butyl acrylate-styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants.
Julio C. Garay-Jimenez (2009)
10.1016/j.biomaterials.2009.01.052
Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles.
Evan M. Hetrick (2009)
10.2174/138955709787847976
Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery.
A. Masotti (2009)
10.7748/NS2005.07.19.43.59.C3906
The physiological basics of wound healing.
C. Johnstone (2005)
10.1039/B515219B
Reducing implant-related infections: active release strategies.
Evan M. Hetrick (2006)
10.3109/10409230903307311
The A–Z of bacterial translation inhibitors
D. Wilson (2009)
10.1111/j.1523-5378.2009.00695.x
Helicobacter pylori and Clinical Aspects of Gastric Cancer
J. Bornschein (2009)
10.1002/cmdc.200600171
Topical Delivery of Silver Nanoparticles Promotes Wound Healing
J. Tian (2007)
10.1021/JA0686864
Nitric oxide-releasing fabrics and other acrylonitrile-based diazeniumdiolates.
F. Derosa (2007)
10.2741/2947
Platelets and wound healing.
A. Nurden (2008)
10.1016/j.mib.2009.08.001
The clinical consequences of antimicrobial resistance.
L. Rice (2009)
10.1080/10611860902718649
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori
S. Ramteke (2009)
10.1016/j.ejps.2009.02.010
Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles.
M. Agüeros (2009)
10.1086/591407
Historical and regulatory perspectives on the treatment effect of antibacterial drugs for community-acquired pneumonia.
M. Singer (2008)
10.1111/j.1365-2702.2007.02264.x
A systematic review of silver-releasing dressings in the management of infected chronic wounds.
S. Lo (2008)
10.1086/422458
Staphylococcus aureus with reduced susceptibility to vancomycin.
S. Cosgrove (2004)
Role of nitric oxide, nitroxidative and oxidative stress in wound healing.
Amit Soneja (2005)
10.2741/2559
Adult and fetal wound healing.
B. Hantash (2008)
10.1016/J.IJSU.2005.10.007
Nanotechnology, nanomedicine and nanosurgery.
R. Freitas (2005)
10.1111/j.1524-475X.2009.00466.x
Interactions between extracellular matrix and growth factors in wound healing
G. Schultz (2009)
10.1615/CRITREVTHERDRUGCARRIERSYST.V23.I4.10
Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives.
M. Nahar (2006)
10.1111/j.1365-2133.2008.08449.x
Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars
B. Cheng (2008)
10.1007/s10646-008-0217-x
What can be inferred from bacterium–nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles?
A. Neal (2008)
10.1016/j.jconrel.2008.05.020
Antibiotic-eluting medical devices for various applications.
M. Zilberman (2008)
10.1111/j.1524-475X.2007.00280.x
Wound‐healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes
S. Spiekstra (2007)
10.1016/j.cps.2009.05.011
Topical antimicrobial agents for burn wounds.
D. Greenhalgh (2009)
10.1126/SCIENCE.287.5457.1427
Out of Eden: stem cells and their niches.
F. Watt (2000)
10.1016/j.suc.2009.03.009
The science of wound bed preparation.
Jaymie Panuncialman (2009)
10.1002/JPS.21183
Past, present, and future technologies for oral delivery of therapeutic proteins.
R. Singh (2008)
10.1088/0957-4484/21/10/105103
Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
S. P. Chakraborty (2010)
10.1097/00000658-198609000-00011
Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF).
D. Knighton (1986)
10.1023/A:1011032328064
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
A. Lamprecht (2004)
10.1021/bm801103c
Growth factor delivery approaches in hydrogels.
A. Silva (2009)
10.1086/605539
Bad bugs, no drugs: no ESCAPE revisited.
L. Peterson (2009)
10.1590/S0102-86502009000600007
Evaluation of chitosan gel with 1% silver sulfadiazine as an alternative for burn wound treatment in rats.
Ednaldo Gomes do Nascimento (2009)
10.1128/JB.00975-09
Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal.
N. Barraud (2009)
10.1038/cdd.2009.195
Molecular mechanisms of late apoptotic/necrotic cell clearance
I. K. Poon (2010)
10.1016/j.niox.2008.08.002
Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure.
C. Miller (2009)
10.2174/138920009790274522
Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections.
Pei-Feng Liu (2009)
10.1056/NEJMOA025025
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.
S. Chang (2003)
10.12968/JOWC.2009.18.8.43636
Role of macrophages in normal wound healing: an overview.
R. Adamson (2009)
10.1111/J.1524-4725.2005.31612
Normal Cutaneous Wound Healing: Clinical Correlation with Cellular and Molecular Events
C. Baum (2005)
10.1081/RRS-120014595
SPECIFIC STIMULATION OF MIGRATION OF HUMAN KERATINOCYTES BY μ -OPIATE RECEPTOR AGONISTS
P. Bigliardi (2002)
10.1021/mp900056g
Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
J. Jain (2009)
10.1128/AAC.49.3.1222-1224.2005
Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure
T. Levin (2005)
10.1002/humu.21067
Molecular pathology of the fibroblast growth factor family
P. Krejcí (2009)
10.1159/000079887
Mu-Opiate Receptor and Beta-Endorphin Expression in Nerve Endings and Keratinocytes in Human Skin
M. Bigliardi‐Qi (2004)
10.1016/j.mam.2008.05.002
Progress in matrix metalloproteinase research.
G. Murphy (2008)
10.1016/j.nano.2008.07.004
In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications.
Kerriann Greenhalgh (2009)
10.1088/0957-4484/19/05/055302
A novel method to obtain chitosan/DNA nanospheres and a study of their release properties.
A. Masotti (2008)
10.1007/978-0-387-69163-3_2
Silver as a Disinfectant
Nadia Silvestry-Rodriguez (2007)
10.1007/s11095-009-9834-1
Selective Adhesion of Nanoparticles to Inflamed Tissue in Gastric Ulcers
S. Hasani (2009)
10.1111/j.1472-765X.2009.02648.x
The benefits of silver in hygiene, personal care and healthcare
V. Edwards-Jones (2009)
10.1016/j.ejpb.2009.03.009
Influences of opioids and nanoparticles on in vitro wound healing models.
Nadine B Wolf (2009)
10.1111/j.1067-1927.2005.130207.x
Opioids heal ischemic wounds in the rat
T. Poonawala (2005)
10.1007/978-0-387-78952-1_6
Interaction between the coagulation and complement system.
Umme Amara (2008)
10.1016/j.suc.2008.09.002
Common microbial pathogens in surgical practice.
M. Qadan (2009)
10.1016/J.BURNS.2006.06.010
Effect of silver on burn wound infection control and healing: review of the literature.
B. Atiyeh (2007)
10.1038/35102160
Stem cells find their niche
A. Spradling (2001)
10.1016/j.taap.2009.02.020
Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells.
S. Arora (2009)
10.2174/157489107779561706
Antibiotic treatment strategies for Helicobacter pylori infection.
S. Campo (2007)
10.1038/ajg.2009.45
Effect of Proton Pump Inhibitors on Vitamins and Iron
K. McColl (2009)
10.2147/IJN.S614
Potential clinical applications of quantum dots
Igor L. Medintz (2008)
10.1016/j.ijpharm.2009.12.024
Gene delivery nanoparticles fabricated by supercritical fluid extraction of emulsions.
Aaron S. Mayo (2010)
10.1517/13543776.15.2.125
Silver and its application as an antimicrobial agent
A. Melaiye (2005)
10.1016/j.addr.2008.03.017
Porous silicon in drug delivery devices and materials.
E. Anglin (2008)
10.1002/jbm.a.32626
Hyaluronan-based scaffold for in vivo regeneration of the rat vena cava: Preliminary results in an animal model.
L. Pandis (2010)
10.1016/J.BMCL.2006.09.098
Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents.
E. Turos (2007)
10.1111/j.1523-5378.2009.00697.x
Helicobacter pylori and Non‐malignant Diseases
T. Furuta (2009)
10.1007/s11845-008-0173-8
What is new in the management of Helicobacter pylori?
B. Egan (2008)
10.1517/14712598.4.8.1213
Nanoparticle-mediated gene delivery: state of the art
M. Ravi Kumar (2004)
10.1146/ANNUREV.BIOCHEM.67.1.753
TGF-beta signal transduction.
J. Massagué (1998)
10.1111/j.1523-5378.2010.00774.x
Treatment of Helicobacter pylori Infection 2010
A. O’Connor (2010)
10.1007/s10856-008-3566-3
Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study
B. Zavan (2009)
10.1016/j.ijantimicag.2009.01.017
The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver.
D. Monteiro (2009)
10.1021/nn700183g
Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria.
A. Kell (2008)
10.1586/erd.09.57
Recent advances in dermal wound healing: biomedical device approaches
S. Rizzi (2010)
10.3844/AJBBSP.2008.345.353
A Review on Supercritical Fluid Extraction as New Analytical Method
K. A. Abbas (2008)
10.1096/fj.01-0250com
Mechanisms of wound reepithelialization: hints from a tissue‐engineered reconstructed skin to long‐standing questions
A. M. Laplante (2001)
10.1038/jid.2009.149
Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing.
R. Weller (2009)
10.1086/524891
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
B. Spellberg (2008)
Development of an electrolytic silver-ion generator for water sterilization in Apollo spacecraft water systems. Apollo applications program Final report
C. F. Albright (1967)
10.1111/j.1742-1241.2009.02011.x
Novel oral anticoagulants
C. Khoo (2009)
10.1016/S0169-409X(97)00125-7
Protein release from gelatin matrices.
Ikada (1998)
10.1016/j.burns.2008.05.029
The year in burns 2007.
S. Wolf (2008)
10.1098/rsif.2008.0327
Fibrin gels and their clinical and bioengineering applications
P. Janmey (2008)
10.1126/science.1175439
Endogenous Nitric Oxide Protects Bacteria Against a Wide Spectrum of Antibiotics
I. Gusarov (2009)
10.1021/bm900985h
Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
Chiung-Hung Chang (2010)
10.1016/J.JCONREL.2005.09.023
Gelatin as a delivery vehicle for the controlled release of bioactive molecules.
S. Young (2005)
10.1023/A:1019854327540
Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport
I. Behrens (2004)
10.1111/j.1600-0625.2009.00844.x
Opioids and the skin – where do we stand?
P. Bigliardi (2009)
10.1007/10_023
Gene-modified tissue-engineered skin: the next generation of skin substitutes.
S. Andreadis (2007)
10.1016/j.ijpharm.2009.06.014
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
S. Salmaso (2009)
10.1016/j.coph.2009.07.009
An update on community-associated MRSA virulence.
S. Kobayashi (2009)
10.1002/smll.200801602
Protein-based nanomedicine platforms for drug delivery.
A. Maham (2009)
10.1016/j.addr.2008.11.002
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
S. Lai (2009)



This paper is referenced by
10.2147/IJN.S213836
In vitro–in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin
Walaa Ebrahim Abd El Hady (2019)
10.1016/B978-0-323-42865-1.00002-7
Nanotechnology approaches for skin wound regeneration using drug-delivery systems
Itxaso Garcia-Orue (2016)
10.1016/j.carbpol.2015.03.010
Novel zinc alginate hydrogels prepared by internal setting method with intrinsic antibacterial activity.
M. C. Straccia (2015)
10.1016/j.cis.2011.05.008
Silver polymeric nanocomposites as advanced antimicrobial agents: classification, synthetic paths, applications, and perspectives.
P. Dallas (2011)
10.4103/2347-9264.139698
Current and future applications of nanotechnology in plastic and reconstructive surgery
Dana Petersen (2014)
10.33073/PJM-2011-001
New antibacterial therapeutics and strategies.
A. Kurek (2011)
10.1007/s11356-020-10100-y
Current developments in the nanomediated delivery of photoprotective phytochemicals
Nimmy Kumar (2020)
10.2174/1381612821666150901095838
(Phospho)lipid-based Nanosystems for Skin Administration.
Ž. Vanić (2015)
10.1111/j.1600-0625.2012.01542.x
Tissue engineering for the management of chronic wounds: current concepts and future perspectives
V. Wong (2012)
10.1063/1.5100698
Nano composite material of chitosan for wound healing: A review
R. Mala (2019)
10.2147/NSA.S14263
Fullerene fine particles adhere to pollen grains and affect their autofluorescence and germination.
H. Aoyagi (2011)
10.2217/nnm.12.67
The purview of nitric oxide nanoparticle therapy in infection and wound healing.
D. A. Sanchez (2012)
10.1515/ntrev-2017-0162
Analyzing polymeric nanofibrous scaffold performances in diabetic animal models for translational chronic wound healing research
N. Goonoo (2017)
10.15171/apb.2018.046
Nanotechnology in Wound Healing; Semisolid Dosage Forms Containing Curcumin-Ampicillin Solid Lipid Nanoparticles, in-Vitro, Ex-Vivo and in-Vivo Characteristics
Solmaz Ghaffari (2018)
10.1007/s10856-015-5543-y
Inhibition of pathogenic bacterial growth on excision wound by green synthesized copper oxide nanoparticles leads to accelerated wound healing activity in Wistar Albino rats
R. Sankar (2015)
10.1016/B978-0-323-42862-0.00008-0
Nanostructured scaffold and its bioactive potentials in bone tissue engineering
L. Wang (2016)
"Nitric oxide nanoparticles have spawned many new avenues of investigation due to the diatomic radical's intrinsic antimicrobial, cell signaling and immunoregulatory properties ."
David Alejandro Sanchez (2012)
10.1007/s10856-014-5193-5
Wound healing activity of Origanum vulgare engineered titanium dioxide nanoparticles in Wistar Albino rats
R. Sankar (2014)
10.1155/2013/312747
Silver Nanoparticles and Mitochondrial Interaction
E. Bressan (2013)
10.1007/15695_2018_133
Electrospun Antimicrobial Wound Dressings: Novel Strategies to Fight Against Wound Infections
Liis Preem (2018)
10.1016/B978-0-323-42865-1.00013-1
Advances in the field of soft tissue engineering: From pure regenerative to integrative solutions
D. Ficai (2016)
10.1016/j.fct.2015.08.013
Assessment of total silver and silver nanoparticle extraction from medical devices.
Eric M. Sussman (2015)
10.1016/j.ijbiomac.2016.05.021
Wound healing of different molecular weight of hyaluronan; in-vivo study.
Moustafa M G Fouda (2016)
10.3934/MEDSCI.2017.3.352
Chitosan-Based Nanomaterials for Skin Regeneration
M. T. Pelegrino (2017)
10.1097/PSN.0b013e3182701824
Nanotechnology Applications in Plastic and Reconstructive Surgery: A Review
Joe Parks (2012)
10.1146/ANNUREV-FLUID-010313-141413
Particle Transport in Therapeutic Magnetic Fields
I. Puri (2014)
10.2147/IJN.S246601
Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
Reham Mokhtar Aman (2020)
10.1016/j.etap.2013.07.005
Green synthesis of silver nanoparticles: an approach to overcome toxicity.
Nidhija Roy (2013)
10.1002/APP.43260
Design and in vitro investigation of nanocomposite hydrogel based in situ spray dressing for chronic wounds and synthesis of silver nanoparticles using green chemistry
A. Kumar (2016)
10.1016/j.ijbiomac.2017.12.133
Chitosan-silver nanocomposites in goldfish aquaria: A new perspective in Lernaea cyprinacea control.
N. Abu-Elala (2018)
Potential roles of suppressor of cytokine signaling in wound healing
K. Doi (2016)
10.2174/1567201815666180918110134
Aspects of Nanomaterials in Wound Healing.
Srijita Chakrabarti (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar